Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

DOI 10.1038/cr.2016.151

Cited by (1,001)

Items 801–900 of 1,001

Immunometabolism: a new dimension in immunotherapy resistance
Chaoyue Xiao, Wei Xiong, Yiting Xu, Jian Peng Zou, Yue Zeng, Junqi Liu, Yurong Peng, Chunhong Hu, Fang Wu · 2023 · Frontiers of Medicine
What happens to regulatory T cells in multiple myeloma
Huixian Chen, Xueling Wang, Yan Wang, Xiaotian Chang · 2023 · Cell Death Discovery
The significance of targeting lysosomes in cancer immunotherapy
Yanxin Xu, Bo Shao, Yafeng Zhang · 2024 · Frontiers in Immunology
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions
Thomas Enzler, Jiaqi Shi, Jake J. McGue, Brian D. Griffith, Lei Sun, Vaibhav Sahai, Hari Nathan, Timothy L. Frankel · 2024 · International Journal of Molecular Sciences
Autophagy‐Inducing MoO 3‐x Nanowires Boost Photothermal‐Triggered Cancer Immunotherapy
Lizhen He, Qi Chen, Qichen Lu, Meijin Yang, Bin Xie, Tianfeng Chen, Xun Wang · 2024 · Angewandte Chemie International Edition
The host protecting the tumor from the host — targeting PD‑L1 expressed by host cells
David H. Munn · 2018 · Journal of Clinical Investigation
Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy
Naama Margolis, Ettai Markovits, Gal Markel · 2019 · Advanced Drug Delivery Reviews
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model
Hai-Jun Hu, Xiu Liang, Hai-Lang Li, Huai-yuan Wang, Jin-Fa Gu, Lan-Ying Sun, Jing Xiao, Jin-Qing Hu, Ai-Min Ni, Xin-Yuan Liu · 2021 · Cancer Immunology and Immunotherapy
Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP+ Blood Vessels in Mouse MC38 Tumors
Charlotte Bertrand, Pierre Van Meerbeeck, Grégoire de Streel, Noora Vaherto, Fatima Benhaddi, Loïc Rouaud, Agnès Noël, Pierre G. Coulie, Nicolas van Baren, Sophie Lucas · 2021 · Frontiers in Immunology
Extracellular Matrix-Based Gene Expression Signature Defines Two Prognostic Subtypes of Hepatocellular Carcinoma With Different Immune Microenvironment Characteristics
Hui Jun Tang, Tingting You, Zhao Sun, Chunmei Bai, Yingyi Wang · 2022 · Frontiers in Molecular Biosciences
Innate Lymphoid Cells: Role in Immune Regulation and Cancer
Douglas C. Chung, Nicolas Jacquelot, Maryam Ghaedi, Kathrin Warner, Pamela S. Ohashi · 2022 · Cancers
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer
Savvas Papageorgiou, Sarah L. Pashley, Laura O’Regan, Sam Khan, Richard W. Bayliss, Andrew M. Fry · 2022 · Cancers
Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy
Pankaj Kumar, Amit Kumar, Sadiya Parveen, John R. Murphy, William R. Bishai · 2019 · Immunotherapy
Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function
Aiting Wang, Mengdi Yang, Rui Liang, Fangming Zhu, Fuxiang Zhu, Xinnan Liu, Yichao Han, Ruirong Lin, Xiaoxia Wang, Dan Li et al. · 2020 · Frontiers in Immunology
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
Wei Xiong, Liuling Xiao, Rui Duan, Qiang Wang, Miao Xian, Chuanchao Zhang, Su Pan, Yabo Li, Ling Zhong, Jianfei Qian et al. · 2025 · Journal for ImmunoTherapy of Cancer
The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells
Hanqing Yu, Ruiliang Yang, Meixiang Li, Dan Li, Yuanqing Xu · 2025 · Frontiers in Immunology
The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer
Ana S. Leal, Jessica A. Moerland, Di Zhang, Sarah Carapellucci, Beth Lockwood, Teresa Krieger-Burke, Bilal Aleiwi, Edmund L. Ellsworth, Karen T. Liby · 2021 · Cancers
Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironment
Chen Zhang, Di Sun, Chao Li, Yi Liu, Yue Zhou, Jiantao Zhang · 2022 · The International Journal of Biochemistry & Cell Biology
WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma
Yu Zhang, Xiaoxiao Tian, Yanli Bai, Xianmin Liu, Jingjing Zhu, Lamei Zhang, Jinliang Wang · 2022 · Mammalian Genome
Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
Zhiyong Li, Yang Liu, Huijie Yi, Ting Cai, Yunwei Wei · 2022 · Frontiers in Genetics
Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease
Xiuxing Liu, Qi Jiang, Jianjie Lv, Shizhao Yang, Zhaohao Huang, Runping Duan, Tianyu Tao, Zhaohuai Li, Rong Ju, Yingfeng Zheng et al. · 2022 · JCI Insight
Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma
Sicheng Wan, Ulrich Aymard Ekomi Moure, Ruochen Liu, Chaolong Liu, Kun Wang, Longfei Deng, Ping Liang, Hongjuan Cui · 2022 · Frontiers in Immunology
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study
Xiaoyue Du, Shaodi Wen, Run Shi, Jingwei Xia, Ruotong Wang, Yihan Zhang, Banzhou Pan, Xiaoliu Wu, Wei Zhu, Jifeng Feng et al. · 2023 · BMC Cancer
GPR65 as a potential immune checkpoint regulates the immune microenvironment according to pan-cancer analysis
Liangliang Wang, Lele Sun, Hao Sun, Yunhong Xing, Shidong Zhou, Guoshuai An, Jian Li, Kang Ren, Junhong Sun · 2023 · Heliyon
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
Ping Liao, Mengmeng Jiang, Md Sahidul Islam, Yiru Wang, Xin Chen · 2023 · Frontiers in Immunology
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor
Xiao-Fang Yi, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shuling Zhang, Le‐Tian Huang, Cheng‐Bo Han, Jie‐Tao Ma · 2023 · Biomedicine & Pharmacotherapy
Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma
Ang Li, Bai Ji, Yongsheng Yang, Bicheng Ye, Qinmei Zhu, Xintong Hu, Yong Liu, Peiwen Zhou, Juanjuan Liu, Ranran Gao et al. · 2023 · Frontiers in Immunology
Synergistic strategy based on mild phototherapy and deep tumor hypoxia reversal comprehensively remodels the tumor microenvironment for improved immunotherapy
Linlin Tao, Gang Cheng, Fangnan Lv, Ruiqi L. Wang, Nan Yang, Zuhang Xing, Boyu Gu, Siyuan Meng, Wei Xu, Meirong Huo · 2023 · Chemical Engineering Journal
Postbiotics in oncology: science or science fiction?
Anna Kudra, Karolina Kaźmierczak-Siedlecka, Bartosz Kamil Sobocki, Damian Muszyński, Joanna Połom, Ludovico Carbone, Luigi Marano, Franco Roviello, Leszek Kalinowski, Ewa Stachowska · 2023 · Frontiers in Microbiology
Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
Mingze He, Dongqi Zhang, Yu Cao, Changliang Chi, Zitong Zeng, Xinyi Yang, Guodong Yang, Kritika Sharma, Kebang Hu, Mikhail E. Enikeev · 2023 · Heliyon
Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index
Rihan Wu, Ru Ma, Xiaojun Duan, Jiandong Zhang, Kexin Li, Lei Yu, Mingyang Zhang, Pengxia Liu, Changshan Wang · 2023 · Frontiers in Immunology
Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy
Luyao Tian, Xia Li, Lanping Guo, Luqi Huang, Xiong‐Zhi Wu, Wenyuan Gao · 2024 · Coordination Chemistry Reviews
Vps34 sustains Treg cell survival and function via regulating intracellular redox homeostasis
Peiran Feng, Quanli Yang, Liang Luo, Zerong Guan, Jiamin Fu, Mingyue Zhao, Wanqing Meng, Shuo Wan, Junming He, Zhizhong Li et al. · 2024 · Cell Death and Differentiation
Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs
Cuicui Guo, Xiaodong Dai, Yulei Du, Xiumei Xiong, Xun Gui · 2024 · Cancer Immunology Immunotherapy
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
Jesús Rodríguez-Pascual, Ángel Ayuso‐Sacido, Cristóbal Belda-Iniesta · 2019 · Cancer Drug Resistance
Characteristics of Peripheral Immune Function in Reproductive Females with Uterine Leiomyoma
Zhi-Qin Liu, Mei-Yin Lu, Ruliang Sun, Zhinan Yin, Bin Liu, Yangzhe Wu · 2019 · Journal of Oncology
Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics
Bingnan Chen, Di Wang, Jiapo Li, Yue Hou, Chong Qiao · 2020 · Frontiers in Oncology
Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
Junnan Guo, Mingqi Li, Shen-Hui Deng, Chen Chen, Ni Yin, Binbin Cui, Yanlong Liu · 2021 · Frontiers in Oncology
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
Jessica Waibl Polania, Emily Lerner, Daniel S. Wilkinson, Alexandra M. Hoyt-Miggelbrink, Peter Edward Fecci · 2021 · Frontiers in Immunology
Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma
Xiao Li, Mengke Liu, Qing Shi, Ying Fang, Di Fu, Zhixiang Shen, Hongmei Yi, Li Wang, Weili Zhao · 2022 · Hematological Oncology
Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients
Mohammad A. Al-Mterin, Khaled Murshed, Alhasan Alsalman, Ala Abu-Dayeh, Eyad Elkord · 2022 · BMC Cancer
ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
Ran Li, Xiaolu Wu, Kai Xue, Junmin Li · 2022 · Cancer Cell International
Strategies to sensitize cancer cells to immunotherapy
Andrew George, İlyas Şahin, Benedito A. Carneiro, Don Steven Dizon, Howard P. Safran, Wafik S. El‐Deiry · 2021 · Human Vaccines & Immunotherapeutics
The critical role of NAT10-mediated N4-acetylcytidine modification in tumor immunity
Chunhong Li, Xiulin Jiang, YingDong Jia, Qiang Zhou, Yixiao Yuan, Qiang Wang · 2025 · Frontiers in Immunology
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Erin Gourley Reid, Kelly Anne Shimabukuro, Page C. Moore, Richard F. Ambinder, Jack D. Bui, Semi Han, Otoniel Martı́nez-Maza, Dirk P. Dittmer, David Michael Aboulafia, Elizabeth Y. Chiao et al. · 2022 · Clinical Cancer Research
Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model
Run‐Qi Guo, Jin-Zhao Peng, Yuanming Li, Xiaoguang Li · 2022 · Cell Cycle
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma
Hui Zeng, Jinfeng Wang, Biaoming Xu, Hongyu Deng, Mingjing Peng, Rilin Deng, Song Shang, Qi Qi, Junjun Junjun, Jinguan Lin et al. · 2023 · Oncology Reports
Advances in chimeric antigen receptor T cells therapy in the treatment of breast cancer
Qingjie He, Haibo Hu, Fan Yang, Dong Eun Song, Xiaoling Zhang, Xiangpeng Dai · 2023 · Biomedicine & Pharmacotherapy
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, Oumayma Naji, Konala Priyanka Reddy, Rizwan ullah Sadiqi, Abdallah Badou · 2023 · Frontiers in Oncology
Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer
Yongdong Guo, Ronglin Wang, Jingjie Shi, Cheng Yang, Peixiang Ma, Jie Min, Ting Zhao, Lei Hua, Yang Song, Junqiang Li et al. · 2023 · Journal for ImmunoTherapy of Cancer
Metronomic chemotherapy, dampening of immunosuppressive cells, antigen presenting cell activation, and T cells. A quartet against refractoriness and resistance to checkpoint inhibitors
Giulia Bravetti, Paolo Falvo, Giovanna Talarico, Stefania Orecchioni, Francesco Bertolini · 2023 · Cancer Letters
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
Diego F. Chamorro, Lauren K. Somes, Valentina Hoyos · 2023 · Cancers
RETRACTED ARTICLE: Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer
Shi Fu, Zhiyong Tan, Hongjin Shi, Junhao Chen, Yawei Zhang, Chunming Guo, Wei Feng, Haole Xu, Jiansong Wang, Haifeng Wang · 2024 · npj Precision Oncology · Retracted
Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?
Alexandra M. Mowday, Jella van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Jerome Dubois, Philippe Lambin, Jan Theys, Adam Vorn Patterson · 2024 · Critical Reviews in Microbiology
Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer
Chang Jiang, Qingyang Feng, Yihao Mao, Zhiyuan Zhang, Yuqiu Xu, Yijiao Chen, Peng Zheng, Songbin Lin, Feifan Shen, Zhuojian Zhang et al. · 2024 · International Immunopharmacology
Restoring Treg/Th17 cell balance in ulcerative colitis through HRas silencing and MAPK pathway inhibition
Siwei Wang, Wenhao Su, Xiaohan Wu, Weiguo Dong · 2024 · International Immunopharmacology
Research progress on the multi-omics and survival status of circulating tumor cells
Qingming Xie, Shilei Liu, Sai Zhang, Liqiu Liao, Zhi Xiao, Shouman Wang, Pengfei Zhang · 2024 · Clinical and Experimental Medicine
Extracellular vesicle-mediated communication between CD8+ cytotoxic T cells and tumor cells
Zeyu Huang, Xuehui Liu, Qinghao Guo, Yihang Zhou, Linlin Shi, Qingjin Cai, Shupei Tang, Qin Ouyang, Ji Zheng · 2024 · Frontiers in Immunology
Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature
Angus Nnamdi Oli, Samson Adedeji Adejumo, Adekunle Babajide Rowaiye, Joyce Oloaigbe Ogidigo, Jarrad Hampton‐Marcell, Gordon C. Ibeanu · 2024 · Journal of Immunology Research
Cancer-Associated Fibroblasts as the “Architect” of the Lung Cancer Immune Microenvironment: Multidimensional Roles and Synergistic Regulation with Radiotherapy
Zheng Shi, Cuilan Hu, Huijuan Li, Chao Sun · 2025 · International Journal of Molecular Sciences
Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection
Raquel Matavele Chissumba, Eduardo Namalango, Vânia Maphossa, Ivalda Macicame, Nilesh Bhatt, Christina S. Polyak, Merlin Lee Robb, Nelson L. Michael, Ilesh Vinodrai Jani, Luc Kestens · 2017 · BMC Immunology
Targeting regulatory T cells for improving cancer therapy: Challenges and prospects
Bilikere Srinivasa Rao Dwarakanath, Abdullah Farooque, Seema Gupta · 2018 · Cancer Reports
MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
Yixin Yang, Christopher Alderman, Ayoub Sehlaoui, Yuan Xiao, Wei Wang · 2018 · Canadian Journal of Gastroenterology and Hepatology
Organized immune cell interactions within tumors sustain a productive T-cell response
Maria Andrea Cardenas, Nataliya Prokhnevska, Haydn Thomas Kissick · 2020 · International Immunology
Loss of natural resistance to schistosome in T cell deficient rat
Liaoxun Lu, Junjian Hu, Tianzhu Chao, Zhijun Chen, Zhuangzhuang Liu, Xinsong Luo, Yinming Liang, Pei He, Lichen Zhang · 2020 · PLoS neglected tropical diseases
Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant
Chiao‐Fang Teng, Tsai‐Chung Li, Ting Wang, Da-Ching Liao, Yi-Hsuan Wen, Tzu‐Hua Wu, John Wang, Han‐Chieh Wu, Woei‐Cherng Shyu, Ih‐Jen Su et al. · 2021 · Scientific Reports
Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment
Daniela Laura Papademetrio, María Noé Garcia, Daniel Grasso, Elida E. Alvarez · 2021 · Frontiers in Oncology
The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma
Thuan Duc Lao, Minh Trong Quang, Thuy Ai Huyen Le · 2021 · Asian Pacific Journal of Cancer Prevention
The relative change in regulatory T cells / T helper lymphocytes ratio as parameter for prediction of therapy efficacy in metastatic colorectal cancer patients
Tong Xu, LU Jie-zhen, Han‐Xiang An · 2017 · Oncotarget
The significance role of regulatory T cells in the persistence of infections by intracellular bacteria.
Parisa Sabbagh, A. Karkhah, H. Nouri, M. Javanian, S. Ebrahimpour · 2018 · Infection, Genetics and Evolution
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity
Rosmely Hernandez, Kevin H. Toomer, Janika Põder, Alicia Santos Savio, Sunnie Hsiung, Thomas R. Malek · 2020 · Cancer Immunology Immunotherapy
Therapy resistance: Modulating evolutionarily conserved heat shock protein machinery in cancer
Ilona Skrabalak, Alicja Rajtak, Beata Małachowska, Natalia Skrzypczak, Karin A. Skalina, Chandan Guha, Jan Kotarski, Karolina Okła · 2025 · Cancer Letters
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
Kelly M. Mahuron, Osmaan Shahid, Prachi Sao, Clinton Wu, Alexandra M. Haugh, Laura Ann Huppert, Lauren S. Levine, Margaret M. Lowe, Michael Alvarado, Markee Micu et al. · 2025 · Cancer Research
PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
Sherif Abdelhamed, Xinqun Zhang, Weiping Zeng, Bryan M. Grogan, Luke Schilperoort, Reice D. James, Kelli C. Burley, Samantha M. Sarrett, Lauren Bou, Paromita Raha et al. · 2025 · Molecular Cancer Therapeutics
A systematic review on leptin’s role in defining cancer: special emphasis on immunomodulation, inflammation, and therapeutic interventions
Snehashish Modak, Tamanna Aktar, Debabrata Majumder, Ashish Kr. Singha, Debasish Maiti · 2025 · Genes and Immunity
Redox Metabolism‐Associated Molecular Classification of Clear Cell Renal Cell Carcinoma
Xiangling Wei, Weiming Deng, Zhanwen Dong, You Luo, Xiao Hu, Jinhua Zhang, Zhenwei Xie, Tong Zheng, Yuqin Tan, Zuofu Tang et al. · 2022 · Oxidative Medicine and Cellular Longevity
The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy
Shangbo Lei, Jiamin Jin, Xiangfeng Zhao, Lihua Zhou, Guangying Qi, Jinfeng Yang · 2022 · Experimental Biology and Medicine
MELK is a prognostic biomarker and correlated with immune infiltration in glioma
Haiyan Yang, Huandi Zhou, Guohui Wang, Lei Tian, Haonan Li, Yufeng Zhang, Xiaoying Xue · 2022 · Frontiers in Neurology
ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
Qihang Peng, Jin Li, Qian Wu, Pei Wang, Zhongcui Kang, Yiting Deng, Yu Xiao, Peng Zheng, Feng Ge, Ying Chen · 2023 · International Journal of Molecular Sciences
Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang, Bo Jia · 2023 · BioDrugs
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
Gaia Alberti, Corinne Arsuffi, Alice Pievani, Domenico Salerno, Francesco Mantegazza, Francesco Dazzi, Andrea Biondi, Sarah Tettamanti, Marta Serafini · 2023 · Frontiers in Immunology
Translational research in head and neck cancer: Molecular and immunological updates
Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, Hideaki Takahashi, Toshihiro Kishikawa, Ryuhei Okada, Shigeharu Fujieda, Masafumi Sakashita · 2023 · Auris Nasus Larynx
Targeting regulatory T cells by E7777 enhances CD8 T-cell–mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models
Haider Mahdi, Mary Woodall-Jappe, Preeti Singh, Myron Stefan Czuczman · 2023 · Frontiers in Immunology
The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma
Zhijie Xiao, Siqi Wang, Jun‐Jiang Chen, Yun Li, Yuchen Jiang, Vicky Pui‐Chi Tin, Jia Shuo Liu, Huiyi Hu, Maria Pik Wong, Yihang Pan et al. · 2024 · Advanced Science
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki, Koichi Jinushi, Naoko Higuchi, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Takuro Saito, Atsunari Kawashima et al. · 2024 · BMC Cancer
Disease-specific suppressive granulocytes participate in glioma progression
Jiarui Zhao, Di Wu, Jiaqi Liu, Yang Zhang, Chunzhao Li, Weichen Zhao, Penghui Cao, Shixuan Wu, Mengyuan Li, Wenlong Li et al. · 2024 · Cell Reports
Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions
Huatao Zhou, Zilong Zheng, Chengming Fan, Zijing Zhou · 2025 · Seminars in Cancer Biology
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC
Chien‐Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng‐Heng Wu, Tsung‐Han Wu, J P Fan, Chung‐Wei Su, Po‐Ting Lin, Chien‐Wei Peng, Chan‐Keng Yang et al. · 2025 · Hepatology
Dendritic cells cross-talk with tumour antigen-specific CD8+ T cells, Vγ9γδT cells and Vα24NKT cells in patients with glioblastoma multiforme and in healthy donors
Yuuta Eiraku, H. Terunuma, Mary Jane Yagi, Xiaowu Deng, Andrew J. Nicol, Mie Nieda · 2018 · Clinical & Experimental Immunology
The estrogen pathway as a modulator of response to immunotherapy
Maria A. Velez, Timothy Francis Burns, Laura P. Stabile · 2019 · Immunotherapy
Adverse prognostic impact of regulatory T‐cells in testicular diffuse large B‐cell lymphoma
Marjukka Pollari, Teijo S. Pellinen, Marja‐Liisa Karjalainen‐Lindsberg, Pirkko‐Liisa Kellokumpu‐Lehtinen, Suvi‐Katri Leivonen, Sirpa Leppä · 2020 · European Journal Of Haematology
Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma
Chen Chang, Yaping Chen, Leonard Jeffrey Medeiros, Tsai‐Yun Chen, Kung‐Chao Chang · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations
Qiongzi Qiu, Qing Zhou, Aoran Luo, Xufan Li, Kezhen Li, Wenfeng Li, Mengqian Yu, Md Amanullah, Bingjian Lü, Weiguo Lü et al. · 2021 · Genomics
IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
Yi Zhao, Zhiyu Zhang, Wenbin Lei, Yi Zhi Wei, Renqiang Ma, Yihui Wen, Fanqin Wei, Jun Fan, Xu Yang, Lin Chen et al. · 2021 · Frontiers in Oncology
A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
Xiaolei Gao, Na Zhao, Liying Dong, Xuan Zheng, Yixin Zhang, Chong Ding, Shuyan Zhao, Zeyun Ma, Yixiang Wang · 2021 · Frontiers in Oncology
Engineered nanogels simultaneously implement HDAC inhibition and chemotherapy to boost antitumor immunity via pyroptosis
De‐Run Chen, Yuan Gao, Yao Xiao, Shu‐Cheng Wan, Zhi‐Zhong Wu, Shuo Wang, Xianbin Ma, Zhigang Xu, Zhi‐Jun Sun · 2022 · Applied Materials Today
Development and Validation of Novel Prognostic Models for Immune-Related Genes in Osteosarcoma
Junqing Li, Li Su, Xing Xiao, Feiran Wu, Guijuan Du, Xinjun Guo, Fanguo Kong, Jie Yao, Huimin Zhu · 2022 · Frontiers in Molecular Biosciences
A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
Chongchang Zhou, Yiming Shen, Yangli Jin, Zhisen Shen, Dong Ye, Yi Shen, Hongxia Deng · 2022 · Cancer Medicine
Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3
Qi Wang, Qiong Fang, Yanping Huang, Jin Zhou, Meimei Liu · 2022 · Scientific Reports
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer
Yingkun Xu, Yudi Jin, Shun Gao, Yuan Wang, Chi Qu, Yinan Wu, Nan Ding, Yuran Dai, Linshan Jiang, Shengchun Liu · 2022 · Journal of Oncology